OMNIPAQUE 9 mg/mL (Iohexol SOLUTION) 9 mg/mL

OMNIPAQUE 9 mg/mL is a radiocontrast agent used for diagnostic imaging procedures. This solution, containing iohexol, enhances visibility during X-rays and CT scans, aiding in accurate medical assessments.

Strength

9 mg/mL

Pack Size

10 BOTTLE, PLASTIC in 1 BOX (0407-1415-09) / 500 mL in 1 BOTTLE, PLASTIC

Manufacturer / TM Owner

GE Healthcare Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

OMNIPAQUE 9 mg/mL is primarily used as a contrast medium to improve the clarity of internal structures during imaging studies. It is often administered orally for procedures involving the gastrointestinal tract. The primary keyword here is 'radiocontrast agent', and it is commonly asked, 'what is OMNIPAQUE used for' in medical imaging.

Side Effects

When administered, OMNIPAQUE 9 mg/mL may cause a temporary warming sensation or a metallic taste. Some individuals might experience mild nausea or a feeling of fullness. These effects are generally short-lived and subside quickly.

Precautions & Warnings

OMNIPAQUE 9 mg/mL should be used with caution in individuals with a history of allergic reactions to contrast media. It is important to inform healthcare providers about any existing medical conditions or allergies before administration. Proper handling and storage are essential to maintain the integrity of the solution.

Avoid Interactions

OMNIPAQUE 9 mg/mL may interact with certain medications, particularly those that affect kidney function. It is advisable to consult with a healthcare provider regarding potential interactions, especially if taking other medications or supplements. Alcohol and other substances that affect the central nervous system should be avoided.

Frequently Asked Questions

OMNIPAQUE 9 mg/mL is used as a radiocontrast agent to enhance the visibility of internal structures during diagnostic imaging procedures.

OMNIPAQUE 9 mg/mL is typically administered orally for procedures involving the gastrointestinal tract.

Common side effects may include a temporary warming sensation, metallic taste, mild nausea, or a feeling of fullness.

OMNIPAQUE 9 mg/mL should be used with caution in individuals with a history of allergic reactions to contrast media. Consult a healthcare provider for personalized advice.

OMNIPAQUE 9 mg/mL should be stored as per the manufacturer's instructions to maintain its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.